Operating income also declined in the quarter mainly due to medical cost inflation and higher health care expenses in the U.S. from increased enrollment in health care plans. Currency fluctuations reduced sales by $2.3 billion in the quarter. Medical cost inflation and increased health care enrollments in the U.S. have increased the costs of the company.